The DZL core data set represents the most important lung research parameters. All parameters that are part of at least two disease area core datasets were included.
Kategorie | Parameter | Value Set | Description |
---|---|---|---|
Biometric Data | Gender | ||
Biometric Data | Age at visit | ||
Biometric Data | Height | ||
Biometric Data | Weight | ||
Biometric Data | BMI | ||
Diagnosis | Principle / leading / inclusion diagnosis |
|
Single choice. |
Lung comorbidities | Acute Respiratory Distress Syndrome (ARDS) |
|
Single choice. |
Lung comorbidities | Allergy |
|
Single choice. |
Lung comorbidities | Asthma Bronchiale |
|
Single choice. |
Lung comorbidities | Benign lesions |
|
Single choice. |
Lung comorbidities | Bronchopulmonary Dysplasia (BPD) |
|
Single choice. |
Lung comorbidities | Chronic Resp. Infections excl. TB |
|
Single choice. |
Lung comorbidities | Chronic obstructive pulmonary disease |
|
Single choice. |
Lung comorbidities | Cystic Fibrosis (CF) |
|
Single choice. |
Lung comorbidities | Diffuse parenchymal lung disease (DPLD) |
|
Single choice. |
Lung comorbidities | Obstructive sleep apnea |
|
Single choice. |
Lung comorbidities | Pleural Diseases |
|
Single choice. |
Lung comorbidities | Pneumonia |
|
Single choice. |
Lung comorbidities | Pulmonary Embolism |
|
Single choice. |
Lung comorbidities | Pulmonary Hypertension (PH) |
|
Single choice. |
Lung comorbidities | Regeneration and Organ Replacement |
|
Single choice. |
Lung comorbidities | Thoracic Cancer |
|
Single choice. |
Lung comorbidities | Tuberculosis (TB) |
|
Single choice. |
Non-lung comorbidities | Diabetes |
|
Single choice. |
Non-lung comorbidities | Arterial Hypertension |
|
Single choice. |
Non-lung comorbidities | Coronary Heart Disease |
|
Single choice. |
Non-lung comorbidities | Chronic Virus Infection |
|
Multiple choice. |
Non-lung comorbidities | Chronic Mycobacteriosis |
|
Multiple choice. |
Non-lung comorbidities | Hospital-associated Infection |
|
Multiple choice. |
Non-lung comorbidities | Tumor |
|
Multiple choice. |
Non-lung comorbidities | Neurological Disease |
|
Single choice. |
Non-lung comorbidities | Mental Illness |
|
Single choice. |
Health Questionnaires | MRC | Medical Research Council (MRC) breathlessnes scale | |
Smoking History | Smoking Status | ||
Smoking History | Smoking Amount | ||
Lung Function | FVC observed value | Forced Vital Capacity: the volume of air that can forcibly be blown out after full inspiration | |
Lung Function | FEV1 observed value | Forced Expiratory Volume in 1 second: the volume of air that has been exhaled at the end of the first second of forced expiration | |
Lung Function | TLC observed value | Total Lung Capacity: the volume of air in the lungs at maximum inflation | |
Lung Function | TLC%pred | Total Lung Capacity as percentage of the predicted value | |
Lung Function | RV observed value | Residual Volume: the amount of air remaining in the lungs after maximum exhalation | |
Lung Function | VC observed value | Vital Capacity: the largest volume a patient can exhale after a full inhalation | |
Lung Function | DLCO | Diffusion Capacity: the carbon monoxide uptake from a single inspiration in a standard time (usually 10 sec) | |
Lung Function | sRaw effektiv | Specific Airway Resistance | |
Blood Gas Analysis | Capillary pCO2 | Partial pressure of carbon dioxide in capillary blood | |
Blood Gas Analysis | Capillary pO2 | Partial pressure of oxygen in capillary blood | |
Exercise Testing | 6MWT distance | 6 Minute Walkt Test: the distance walked in 6 minutes | |
Therapy | Supplemental oxygen therapy | ||
Follow-UP | Lost to follow up | ||
Follow-UP | Patient deceased | ||
Performance and Activity | EQ-5D-5L Mobility Score | The mobility dimension of the EQ-5D-5L system introduced by the EuroQol Group. There are similarities to other performance measurements like ECOG, Karnofsky and the WHO performance scale. | |
Biobank Samples | Blood Sample | The availability of blood samples for a certain patient |
Our site uses cookies and similar technologies. By using the site, you consent to the use of cookies.
You can find more information on this in our Privacy Policy.